CLD-201, an allogeneic adipose stem-cell loaded oncolytic virus, received FDA fast track designation for soft tissue sarcoma treatment. Fast track designation expedites drug development and review for ...

The EFTISARC-NEO trial of eftilagimod alfa with radiotherapy and pembrolizumab in resectable soft tissue sarcoma achieved its primary end point. The phase 2 EFTISARC-NEO trial (NCT06128863) evaluating ...

A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), in collaboration ...

At 16, Eldiara Doucette felt pain in her right arm that she struggled to describe. “It could have easily been classified with a standard teenage ‘growing pains,’ which is, unfortunately, how a lot of ...

A remarkably preserved plesiosaur fossil has revealed both smooth and scaly skin, offering new clues about how this ancient sea creature swam and moved along the ocean floor. Some skin cells were so ...

Tindersticks certainly make music for listeners who are in the right mood – which in the case of “Always the Stranger”, with Terry Edwards’ mournful trumpet and Dan McKinna’s cinematic string ...

Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to radiation and surgery reduced relapse risk by 43%. Results showed no ...

LONDON — U.S. regulators have authorized a cutting-edge treatment relying on T cells for a rare cancer that arises in the body’s soft tissues, extending the power of immunotherapies to ...

A previous version of this article appeared on Targeted Oncology ™. Although immunotherapy has become a mainstay of treatment for various types of cancer, it has been less successful in treating ...

Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma. Noting that immunotherapy for soft tissue sarcoma (STS) has ...